Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric ...
While there's no cure yet for Alzheimer's, researchers are finally making more progress in better understanding the disease and working on new treatments that may even reverse it.